The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
The Cool Down on MSN1d
Health officials announce outbreak of dangerous virus with major impact: 'Early diagnosis ... [is] critical'The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...
If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...
A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...
It's a big, germy world out there. If you want to travel with peace of mind, learn the basics of vaccines, illnesses, and ...
The VI Department of Health is closely monitoring H5N1, commonly referred as bird flu or avian flu, and recent developments in the U.S. mainland and Puerto Rico. Recently H5N1 was detected in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback